Prenatal exposure to persistent organic pollutants and rapid weight gain and overweight in infancy

Damaskini Valvi1, Michelle Ann Mendez, Raquel Garcia-Esteban

  • 1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Hospital de Mar Medical Research Institute (IMIM), Barcelona, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain; Department of Experimental and Health Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.

Insights

Prenatal exposure to dichlorodiphenyldichloroethylene (DDE) and hexachlorobenzene (HCB) may increase rapid infant growth and overweight risk. Polychlorinated biphenyls (PCBs) showed no association with postnatal growth in this study.

Area of Science:

  • Environmental Health
  • Pediatrics
  • Toxicology

Background:

  • Persistent organic pollutants (POPs) are environmental contaminants with potential health implications.
  • Prenatal exposure to POPs is a growing concern for child development.
  • Understanding the impact of POPs on early growth is crucial for public health.

Purpose of the Study:

  • To investigate the association between prenatal exposure to specific POPs and infant growth.
  • To determine if prenatal POPs exposure influences the risk of overweight in early childhood.

Main Methods:

  • A Spanish birth cohort study measured dichlorodiphenyldichloroethylene (DDE), hexachlorobenzene (HCB), and polychlorinated biphenyls (PCBs) in maternal serum.
  • Rapid growth was defined by z-score weight gain, and overweight by BMI z-score at 14 months.
  • Generalized linear models were used to analyze POPs associations with growth and overweight outcomes.

Main Results:

  • Prenatal DDE and HCB exposure were positively associated with rapid infant growth.
  • DDE and HCB were also linked to an increased risk of overweight at 14 months.
  • Polychlorinated biphenyls (PCBs) did not show a significant association with postnatal growth.

Conclusions:

  • Prenatal exposure to DDE and HCB may contribute to accelerated early postnatal growth and overweight.
  • Further research is warranted to explore the long-term effects of these POPs on child development.
  • Infant sex, breastfeeding, and maternal BMI may modify the observed POPs-growth associations.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...